Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunization

Muscle and Nerve

Volumn 45, Issue 2, 2012, Pages 209-216

  Wu, Xiaorong ^a   Tuzun, Erdem ^b   Li, Jing ^b   Xiao, Tianlin ^b   Saini, Shamsher S ^b   Qi, Huibin ^b   Allman, Windy ^b   Christadoss, Premkumar ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acetylcholine receptor subunit; Autoimmune disease; Extraocular muscles; Myasthenia gravis; Ocular myasthenia gravis

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ALPHA; CHOLINERGIC RECEPTOR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C5B9; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; COMPLEMENT ACTIVATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; MOUSE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; OCULAR MYASTHENIA GRAVIS; PLASMID; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ARABIDOPSIS PROTEINS; CELL PROLIFERATION; COMPLEMENT C3; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA-DQ ANTIGENS; HUMANS; IMMUNIZATION; INTRAMOLECULAR TRANSFERASES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MUSCLE STRENGTH; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; NEUROMUSCULAR JUNCTION; OCULAR MOTILITY DISORDERS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC;

EID: 84862965423     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22273     Document Type: Article

References (28)

1. Gunji K, Skolnick C, Bednarczuk T, Benes S, Ackrell BA, Cochran B, et al. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine- receptor antibody-negative patients. Clin Immunol Immunopathol 1998;87:276-281.
2. Kusner LL, Puwanant A, Kaminski HJ. Ocular myasthenia: diagnosis, treatment, and pathogenesis. Neurologist 2006;12:231-239.
3. Barton JJ, Fouladvand M. Ocular aspects of myasthenia gravis. Semin Neurol 2000;20:7-20.
4. Christadoss P, Poussin M, Deng C. Animal models of myasthenia gravis. Clin Immunol 2000;94:75-87.
5. Yang H, Wu B, Tüzün E, Saini SS, Li J, Allman W, et al. A new mouse model of autoimmune ocular myasthenia gravis. 2007;48:5101-5111.
6. Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986;321:406-411.
7. Cossins J, Webster R, Maxwell S, Burke G, Vincent A, Beeson D. A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition. Hum Mol Genet 2004;13:2947-2957.
8. Hoffmann K, Muller JS, Stricker S, Megarbane A, Rajab A, Lindner TH, et al. Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit. Am J Hum Genet 2006;79:303-312.
9. Koenen M, Peter C, Villarroel A, Witzemann V, Sakmann B. Acetylcholine receptor channel subtype directs the innervation pattern of skeletal muscle. EMBO Rep 2005;6:570-576.
10. Horton RM, Manfredi AA, Conti-Tronconi BM. The 'embryonic' gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurology 1993;43:983-986.
11. Yu Wai Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord 2005;15:17-23.
12. Kaminski HJ, Kusner LL, Block CH. Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci 1996;37:345-351.
13. Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, et al. Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice. J Clin Invest 2002;109:1111-1120.
14. Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, et al. Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors. Ann NY Acad Sci 2003;998:375-378.
15. Tüzün E, Scott BG, Goluszko E, Higgs S, Christadoss P. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J Immunol 2003; 171:3847-3854.
16. Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 2007;185:136-144.
17. Kaminski HJ, Li Z, Richmonds C, Ruff RL, Kusner L. Susceptibility of ocular tissues to autoimmune diseases. Ann NY Acad Sci 2003; 998:5362-5374.
18. Frueh BR, Hayes A, Lynch GS, Williams DA. Contractile properties and temperature sensitivity of the extraocular muscles, the levator and superior rectus, of the rabbit. J Physiol 1994;475:327-336.
19. Kaminski HJ, Maas E, Spiegel P, Ruff RL. Why are eye muscles frequently involved in myasthenia gravis? Neurology 1990;40:1663-1669.
20. Soltys J, Gong B, Kaminski HJ, Zhou Y, Kusner LL. Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment? Ann NY Acad Sci 2008;1132:220-224.
21. Kaminski HJ, Kusner LL, Nash KV, Ruff RL. The gamma-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris. Neurology 1995;45:516-518.
22. Saini SS, Tüzün E, Christadoss P. The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit. J Neuroimmunol 2005;169:177-179.
23. Wang ZY, Diethelm-Okita B, Okita DK, Kaminski HJ, Howard JF, Conti-Fine BM. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. J Neuroimmunol 2000;108:29-39.
24. Asher O, Neumann D, Witzemann V, Fuchs S. Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis. FEBS Lett 1990;267:231-235.
25. Asher O, Kues WA, Witzemann V, Tzartos SJ, Fuchs S, Souroujon MC. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis. J Immunol 1993;151:6442-6450.
26. Guyon T, Wakkach A, Poea S, Mouly V, Klingel-Schmitt I, Levasseur P, et al. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. J Clin Invest 1998;102:249-263.
27. Poëa-Guyon S, Christadoss P, Le Panse R, Guyon T, De Baets M, Wakkach A, et al. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J Immunol 2005;174:5941-5949.
28. Sheng JR, Li LC, Prabhakar BS, Meriggioli MN. Acetylcholine receptor- alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis? Muscle Nerve 2009;40:279-286.